In this new episode, Guillaume Desachy and I dive into the world of R and its impact on the pharmaceutical industry. Guillaume, a Statistical Science Director at AstraZeneca in Sweden, shares his insights and experiences in fostering an R community within the company. Embarking on the exploration of Guillaume’s journey in building the R at …
Welcome to the third and last part of Moving from SAS to R (here is Part 2) where Thomas Neitmann joins us again to talk about transitioning from SAS to R. We also discuss the new SAS to R course of The Effective Statistician and you’ll learn, if this is the right course for you. …
This episode is the second part of Moving from SAS to R with Thomas. (Here is Part 1) We also discuss the new SAS to R course of The Effective Statistician and you’ll learn, if this is the right course for you. We provide a couple of learnings from the course for you to get …
The use of R in the pharmaceutical and healthcare industry has been increasing over the years, with larger companies like Roche adopting it as their primary statistical software. Others like GSK, NovoNordisk, and Merck make heavy investments into it. In this episode, Thomas Neitmann discusses various lessons from his career within pharma and the role …
As a statistician, you’re likely already familiar with SAS and the value it brings to data analysis. But in this ever-evolving world of statistics and data science, relying on your go-to language might not be enough to stay competitive anymore. The open-source language R is gaining traction within the healthcare industry as a powerful tool …